Are all peptides dangerous?

No. Several TGA-approved peptide medicines are used in clinical practice, including semaglutide for type 2 diabetes and weight management. The concern is with unregulated products sold online, where ingredient content, dose, and purity cannot be verified.

What should I do if I am already using an unprescribed peptide?

NSW Health advises speaking to a GP or health professional before the next dose. If you experience nausea, vomiting, severe abdominal pain, or signs of an allergic reaction, present to an emergency department.

How do I know if a peptide product is TGA-approved?

TGA-approved therapeutic goods are listed on the Australian Register of Therapeutic Goods (ARTG), searchable at tga.gov.au. An unlisted product is not an approved medicine in Australia.

NSW peptide surge: 1,180 ED visits in 14 months

NSW Health data released this week shows 1,180 people presented to emergency departments across New South Wales from July 2025 to September 2026 after taking unregulated peptides. Monthly presentations rose from 5 in July 2025 to almost 220 in September 2026 — a near forty-fold increase in fourteen months.

The products named in the NSW Health warning include BPC-157, GHK-Cu, TB-500, retatrutide and CJC-1295. These aren’t obscure compounds. They’re widely available on social media platforms, marketed for weight loss, anti-ageing and muscle growth. If you’ve spent time in wellness spaces online recently, you’ve likely seen them promoted without context.

That rise in emergency department figures isn’t abstract. These are people who became unwell enough to need acute care, often without fully understanding what they had taken.

The legitimate end of the spectrum

There is a legitimate side to the peptide story, and ignoring it doesn’t serve anyone.

Peptide-based medicines are a real and clinically significant class of drugs. GLP-1 receptor agonists — semaglutide and tirzepatide among them — are peptide-based, TGA-approved, and have changed clinical management of type 2 diabetes and, in selected patients, obesity. These are prescribed by GPs, dispensed through pharmacies, and monitored over time with appropriate clinical oversight.

The enthusiasm for peptides as a broad class of compounds isn’t manufactured from nothing. The underlying science is genuinely active and the approved end of the market has produced important medicines.

What crosses the line

What crosses the line is the completely unregulated ecosystem in which most people encounter these products.

Dr Tim Jones from the RACGP was direct: products often don’t contain the listed ingredients, may arrive in very different doses, or may be mixed with other substances entirely. When you order from an unregulated supplier, you are making a pharmacological decision without the information needed to assess what you’re actually taking.

The TGA approves medicines through a process that verifies identity, potency, purity and manufacturing standards. Products that bypass that process offer none of those assurances. You don’t know what’s in the vial. You don’t know the actual dose. You don’t know what it will do to your kidneys, your liver, or your endocrine system — or what interaction it might have with other medications.

NSW Health has flagged specific risks from unregulated peptides in this cohort: liver damage, kidney damage, allergic reactions, and severe vomiting. Some effects are delayed. Dr Jones noted that the 1,180 emergency department presentations may be the “tip of the iceberg” because some harms take time to manifest, and not everyone who develops symptoms will connect them to a peptide taken days or weeks earlier.

The young people piece

One detail in the ABC Health report deserves particular attention.

Dr Jones said he has seen patients as young as 14 accessing unregulated peptides online, and estimates that at least half the young people he speaks with have considered doing so. Eating disorder dietitian Alex Rodrigues noted that unregulated peptides are being sold and shared within gym communities — a trend she described as concerning in its normalisation.

This isn’t an abstract concern about teenagers. It’s a statement about how seamlessly the online wellness space has made unregulated pharmaceutical products feel like ordinary consumer goods. The signals reaching young people say “this is what people like you do.” The emergency department data says something different.

2 cents

NSW Health Minister Ryan Park said the issue will be discussed with state and territory health ministers. That’s the appropriate governance response, and what follows from those conversations will matter.

For now, the practical position is this: if you are currently using an unprescribed peptide, speaking to your GP before the next dose makes sense. Your GP won’t judge you for having tried it. What they can do is talk through what you were hoping for, whether there’s a clinically appropriate path to that goal, and whether there are any acute concerns based on what you’ve been taking.

If you have symptoms — vomiting, severe abdominal pain, signs of an allergic reaction, unusual fatigue or jaundice — present to an emergency department rather than waiting.

The scale NSW Health is describing isn’t a fringe problem. Monthly presentations rising from 5 to 220 in fourteen months is a trajectory that general practice, emergency departments and regulators will need to respond to together. The data being visible is the starting point.

Verdict: yes — the scale of harm is real, and this is worth knowing about if you move in any wellness or gym-adjacent space, or have young people in your life who do.